Related Experiment Video

Updated: Oct 11, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Treatment of severe atopic dermatitis in childhood with cyclosporin

I Zaki1, R Emerson, B R Allen

  • 1Department of Dermatology, University Hospital, Nottingham, U.K.

The British Journal of Dermatology
|September 1, 1996
PubMed

Insights

Cyclosporin effectively treats severe childhood atopic dermatitis in a short-term study. Most young patients responded well with good tolerance, suggesting it

Area of Science:

  • Pediatric Dermatology
  • Immunosuppressive Therapy

Background:

  • Atopic dermatitis (AD) is a common childhood condition with significant morbidity.
  • Cyclosporin is effective for adult AD, but pediatric data are lacking.
  • Severe refractory AD in children requires safe and effective treatment options.

Purpose of the Study:

  • To evaluate the efficacy and safety of cyclosporin for severe refractory childhood atopic dermatitis.
  • To assess treatment response and tolerability in pediatric patients.

Main Methods:

  • Open-label study of 18 children with severe refractory atopic dermatitis.
  • Initial cyclosporin dose of 5-6 mg/kg/day, adjusted based on response.
  • Monitoring for treatment response, tolerability, serum creatinine, and blood pressure.

Main Results:

  • 16 of 18 patients showed a good or excellent response to cyclosporin.
  • One patient had a moderate response; one patient did not improve.
  • Treatment was well-tolerated with no significant changes in creatinine or blood pressure.

Conclusions:

  • Cyclosporin appears to be an effective and safe short-term treatment for severe childhood atopic dermatitis.
  • Some patients experienced prolonged remission after treatment withdrawal.
  • Further research may explore long-term efficacy and optimal dosing strategies.

More Related Videos

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...